Transradial Approach [LEft vs right] aNd procedural Times during percutaneous coronary procedures: TALENT study ALESSANDRO SCIAHBASI, MD UO Cardiologia,

Slides:

Advertisements

Similar presentations

STEM-AMI OUTCOME TRIAL STem cElls Mobilization in Acute Myocardial Infarction Outcome Trial A national, multicentre, randomised, open-label, Phase.

Advertisements

Impact of Anemia on One-Year Ischemic Events and Mortality Among Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention Steven.

STS 2015 John V. Conte, MD Professor of Surgery Johns Hopkins University School of Medicine On Behalf of the CoreValve US Investigators Transcatheter Aortic.

Comparison of Operator Radiation exposure during Coronary Angiograms and Interventions by Radial and Femoral routes – -Can we decrease the risk with increased.

Comparison of the New Mayo Clinic Risk Scores and Clinical SYNTAX Score in Predicting Adverse Cardiovascular Outcomes following Percutaneous Coronary Intervention.

Radial versus Femoral Randomized Investigation in ST Elevation Acute Coronary Syndrome the RIFLE STEACS study Enrico Romagnoli, MD PhD Principal investigators:

Title: Percutaneous Nephrolithotomy versus Extracorporeal Shockwaves Lithotripsy for Treatment of a mm Single Renal Pelvis Stone Authors: Mohammed.

RADIAL VS FEMORAL ACCESS FOR CORONARY ANGIOGRAPHY AND INTERVENTION IN PATIENTS WITH ACS-( RIVAL) A RANDOMIZED,PARALLEL GROUP, MULTICENTRE TRIAL.

The Radial Approach to Percutaneous Coronary Intervention Is Associated With a Lower Risk for Complications Regardless of Radial Procedure Volume: A Report.

Predictors of Major Vascular Access Site Complications in Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: Insights.

Study by: Granger et al. NEJM, September 2011,Vol No. 11 Presented by: Amelia Crawford PA-S2 Apixaban versus Warfarin in Patients with Atrial Fibrillation.

Francesco Burzotta HOTLINE III, ESC Congress 2007 September 4th 2007, Vienna OPTIMIST: the Outcome of Pci for stent-ThrombosIs MultIcentre STudy Institute.

Left Main Coronary Artery Dissection Complicating Diagnostic Coronary Angiography Layth A. Mimish MBChB, FRCPC, FACC Medical Director The Cardiovascular.

TOTAL Stroke in the TOTAL trial: Randomized trial of manual aspiration Thrombectomy in STEMI TOTAL Trial Investigators.

Raising the standard in treating bifurcation lesions GENNARO SARDELLA MD, FACC,FESC O.U. of Interventional Cardiology Dept. of.

University Medical Center Groningen Thrombus aspiration during primary PCI FZ Thrombus Aspiration during Percutaneous coronary intervention in Acute.

Early high-dose Rosuvastatin for Contrast-Induced Nephropathy Prevention in Acute Coronary Syndrome The PRATO-ACS (Protective effect of Rosuvastatin and.

COURAGE: Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation Purpose To compare the efficacy of optimal medical therapy (OMT)

BEAUTI f UL: morBidity-mortality EvAlUaTion of the I f inhibitor ivabradine in patients with coronary disease and left ventricULar dysfunction Purpose.

Francesco Liistro Cardiovascular Department, Arezzo, Italy Impact of Thrombus Aspiration on Myocardial Tissue Reperfusion and Left Ventricular Functional.

Trans-Radial approach in Overweight Patients Hakim Ben Amer, MD On behalf the TROP study group.

Bridging Oral Anticoagulation with Low Molecular Weight Heparin: Experience in 367 Patients with Renal Insufficiency Heyder Omran, Giso von der Recke,

Around-the-Clock Primary Angioplasty: A Process of Care Analysis Comparing Off-Hours and Normal Hours Treatment of Acute STEMI R Leung, D Lundberg, D Galbraith,

Blood Pressure Lability During Cardiac Surgery Is Associated With Adverse Outcomes Solomon Aronson, Edwin G. Avery, Cornelius Dyke, Joseph Varon, Jerrold.

Acetylcysteine for the prevention of Contrast- induced nephropaThy (ACT) Trial: The ACT Trial Investigators Presenter: Otavio Berwanger (MD; PhD) Chair.

Major Bleeding Is Associated With Increased One-Year Mortality and Ischemic Events in Patients With ACS: Results From the ACUITY Trial Steven V. Manoukian,

International Atomic Energy Agency Can cardiac procedures be graded in complexity and related with dose? L 8.3.

ARMYDA-CIN Trial [Atorvastatin for Reduction of Myocardial Damage during Angioplasty–Contrast-Induced Nephropathy]

Sunil V. Rao MD The Duke Clinical Research Institute The Durham VA Medical Center Duke University Medical Center Transradial PCI in Octogenarians: Caveats,

Prasugrel vs. Clopidogrel for Acute Coronary Syndromes Patients Managed without Revascularization — the TRILOGY ACS trial On behalf of the TRILOGY ACS.

High Versus Standard Clopidogrel Maintenance Dose After Percutaneous Coronary Intervention: Effects on Platelet Inhibition, Endothelial Function and Inflammation.

Transulnar Access Ugo Limbruno Cardiovascular Department, ASL 6 Livorno, Italy.

Trans-Radial Approach for STEMI Evolution of TRA in single center Rationale behind increased TRA use Progression to use in STEMI Data analysis of STEMI.

Radial versus Femoral Approach for Percutaneous Coronary Procedures: A Meta-analysis of Randomized Trials 6th EUROPEAN WORKSHOP ON TRANSRADIAL APPROACH.

TRI vs TFI in STEMI Shenyang Northern Hospital Wang Shouli Han Yalin.

The Impact of Circulation Access in Allogeneic Peripheral Blood Stem Cell Harvest Shang-Hsien Yang1, Tso-Fu Wang2,3, Shu-Hui Wen4, Sung-Chao Chu3, Ruey-Ho.

Safety and Efficacy of Intravenous Enoxaparin in Elective Percutaneous Coronary Intervention: An International Randomised Evaluation One year follow-up.

AICT 2010-Athens Interventional Cardiovascular Therapeutics XI 8-9 OCTOBER 2010 Divani Caravel Hotel, Αthens EARLY CLINICAL OUTCOMES AFTER PROMUS ELEMENT.

Alternative Approach Trans-Ulnar Approach Feasibility of Percutaneous Coronary Intervention Via Transulnar Artery Approach in Selected Patients with Coronary.

Bleeding in Patients Undergoing Percutaneous Coronary Interventions: A Risk Model From 302,152 Patients in the NCDR. Sameer K. Mehta MD, Andrew D. Frutkin.

DOES TRANSRADIAL INTERVENTION IMPACT RADIATION EXPOSURE Dr Jim Nolan University Hospital of North Staffordshire.

Determination of the RAdial versus GrOiN coronary angioplasty The Result of DRAGON Trial Shigeru Saito, MD Department of Cardiology and Catheterization.

Ulnar artery intervention non inferior to radial approach: Reality or myth? AJmer ULnar ARtery working group study. A randomized parallel group Non-Inferiority.

Disclosure Statement of Financial Interest

ARNO TRIAL (Antithrombotic Regimens aNd Outcome) A RANDOMIZED TRIAL COMPARING BIVALIRUDIN WITH UNFRACTIONED HEPARIN IN PATIENTS UNDERGOING ELECTIVE PCI.

FRagmin® and Fast Revascularization during InStablity in Coronary artery disease FRISC II.

Renal Intervention by the Radial Approach Josef Ludwig, Erlangen Angiosoft.NET.

Major Bleeding is Associated with Increased One-Year Mortality and Ischemic Events in Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary.

Issued in 2015 – SCAAR. SCAAR Annual report 2014.

Date of download: 5/30/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Elective Intra-aortic Balloon Counterpulsation During.

Duration Safety and Efficacy of Bivalirudin in patients undergoing PCI: The impact of duration of infusion in ACUITY trial Dr. David Cox Lehigh Valley.

Ten Year Outcome of Coronary Artery Bypass Graft Surgery Versus Medical Therapy in Patients with Ischemic Cardiomyopathy Results of the Surgical Treatment.

The CIAO (Coronary Interventions Antiplatelet-based Only) Study Eugenio Stabile, MD, PHD, FESC, FAHA, Wail Nammas, MD, Luigi Salemme, MD, Giovanni Sorropago,

Impact of Anticoagulation Regimens on Sheath Management and Bleeding in Patients Undergoing Elective Percutaneous Coronary Intervention in the STEEPLE.

Transradial Best Practices for Radial Access

Dr Savvas S Constantinides, MBChB, MD, FRCP Consultant Interventional Cardiologist American Medical Center, Nicosia, Cyprus.

RADIATION EXPOSURE AND VASCULAR ACCESS IN ACUTE CORONARY SYNDROMES:

From ESH 2016 | LB 3: Davide Agnoletti, MD

Angiotensin converting enzyme inhibitors / angiotensin receptor blockers and contrast induced nephropathy in patients receiving cardiac catheterization:

Early high-dose Rosuvastatin for

Lako S, Daka A, Nurka T, Dedej T, Memishaj S

Why Radial Access Should be the Default for Women undergoing PCI?

Transradial Intervention as Access of Choice in STEMI

Sunil V. Rao MD The Duke Clinical Research Center

Angiography-guided PCI

An Analysis of the ACUITY Trial Lincoff AM, JACC Intv 2008;1:639–48

Anemia Is Associated With Increased One-Year Mortality and Ischemic Events in Patients With ACS: Results From the ACUITY Trial Steven V. Manoukian, George.

Implications of Preoperative Thienopyridine Use

National Trends in the Incidence, Management, and Outcomes of Heart Failure Complications in Patients Hospitalized for ST-Segment Elevation Myocardial.

Comparison of radial versus femoral access in patients undergoing invasive management for acute coronary syndromes: evidence from a systematic review and.

Presentation transcript:

Transradial Approach [LEft vs right] aNd procedural Times during percutaneous coronary procedures: TALENT study ALESSANDRO SCIAHBASI, MD UO Cardiologia, Policlinico Casilino – ASL RM B, Rome, Italy

Background Coronary transradial procedures may be performed through right or left radial artery approach (RRA and LRA respectively) Most of studies assessing feasibility of the transradial approach have been performed through RRA, but the LRA may have some important anatomical advantages. Aim of this study was to evaluate safety and efficacy of RRA versus LRA approach in coronary diagnostic and interventional procedures. Policlinico CASILINO

Methods From January 2009 to December 2009 all patients who underwent percutaneous coronary procedures (diagnostic or PCI) Exclusion criteria: previous CABG, acute STEMI, haemodynamic instability, ischemic Allen test. Right Radial Approach Left Radial Approach Policlinico Casilino Policlinico Gemelli Policlinico CASILINO

Primary end point: fluoroscopy time and the Dose Area Product (DAP) adsorbed by the patients. Secondary end-points: contrast amount, cannulation time, access shift rate, number of catheters employed, major complications. A sub-analysis regarding patient’s age and operator’s skillness (senior compared to fellow) was also pre-specified Methods Policlinico CASILINO

1540 consecutive patients were randomized to LRA (770) or RRA (770) 1467 patients 735 LRA732 RRA Diagnostic Group (coronary angiography) 688 patients 344 LRA 344 RRA PCI Group (PCI post angiography or stand alone) Methods Policlinico CASILINO

Results Right Radial (n=770) Left Radial (n=770) P Age (years)65.7 ± ± Sex (Male)526 (68%)527 (68%)0.95 Height (cm)168 ± 8168 ± Weight (Kg) 77 ± BMI 27 ± 428 ± Diabetes (%)208 (27%)238 (31%)0.09 Hypertension (%)539 (70%)520 (68%)0.30 Creatinine (mg/dl)1.05 ± ± GFR (ml/min) 90 ± ± Hemoglobin (g/dl)13.5 ± ± Mean ± standard deviation; BMI: body mass index, GFR: glomerular filtration rate Policlinico CASILINO

Results RRA (n= 732) LRA (n= 735) seconds Fluoroscopy time ( ) ( ) P= Dose Area Product (Fluoroscopy) Gy/cm 2 ( ) ( ) P= Dose Area Product (Fluorography) Gy/cm 2 ( ) ( ) P= 0.40 Results are expressed as median with range in brackets Diagnostic Group (n= 1467) Policlinico CASILINO

Fluoroscopy time seconds ( ) ( ) P= Dose Area Product (Fluoroscopy) Gy/cm 2 ( ) ( ) P= 0.17 Results are expressed as median with range in brackets PCI Group (n= 688) RRA (n= 344) LRA (n= 344) Dose Area Product (Fluorography) Gy/cm 2 ( ) ( ) P= 0.60 Results Policlinico CASILINO

Right Radial (n=770) Left Radial (n=770) P Cannulation Time (min)†5 (2-85)5 (2-60)0.27 Cross over to femoral6 (0.8%)9 (1.2%)0.43 Stroke/TIA1 (0.1%)0 (0%)0.31 Subclavian Tortuosity125 (16%)65 (8%)<0.001 Coronay angiography Contrast medium (ml)*68 ± 3565 ± >2 Catheters84 (11%) 0.98 Coronary intervention Contrast medium (ml)*165 ± ± >1 Catheter43 (13%)42 (12%)0.91 * Mean ± standard deviation; † Median with ranges Results Policlinico CASILINO

Cross-over to femoral: Incidence and classification RRA (n= 770) LRA (n= 770) Overall 14 puncture and radial failure vs 1 epi-aortic failure, p= Puncture Failure Lack of radial canalization Cases P= 0.41 Radial Failure Radial tortuosity/anomalies Severe spasm P= 0.70 P= 0.31 Epi-Aortic Failure Subclavian-aortic tortuosity P= 0.31 Results Policlinico CASILINO

Radial tortuosity OR=18.5; 95%CI, , p< Multivariate analysis Predictors of cross over to femoral OR=2.6; 95%CI, , p< Age >70 years Predictors of subclavian tortuosity OR=2.7; 95%CI, , p< Right radial approach Results Policlinico CASILINO

Results are expressed as median with range in brackets Diagnostic Group (n= 1467) Dose Area Product (Fluoroscopy) Gy/cm 2 ( ) ( ) P= seconds Fluoroscopy time ( ) ( ) P= 0.11 SENIOR RRA (n= 487) LRA (n= 478) FELLOW seconds ( ) ( ) P= Fluoroscopy time RRA (n= 245) LRA (n= 257) Gy/cm 2 ( ) ( ) P= Dose Area Product (Fluoroscopy) Results Policlinico CASILINO

Results are expressed as median with range in brackets Diagnostic Group (n= 1467) Gy/cm ( ) ( ) P= Fluoroscopy time seconds (32-990) ( ) P= Age <70 years RRA (n= 430) LRA (n= 425) Dose Area Product (Fluoroscopy) Fluoroscopy time seconds ( ) ( ) P= ( ) ( ) P= Age ≥70 years RRA (n= 302) LRA (n= 310) Dose Area Product (Fluoroscopy) Gy/cm 2 Results Policlinico CASILINO

Conclusions LRA for coronary angiography and interventions is associated with slight but significant lower fluoroscopy time and radiation dose compared to RRA The LRA advantage seems to be confined to operators at the beginning of learning curve (fellows) and to be more pronounced in older patients Policlinico CASILINO